Search

everythinglearnresearchcommunity

for

Search:↓

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Androgenic steroids can slow down or stop the growth of certain skin fungi.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Method accurately measures finasteride in human plasma.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Topical spironolactone cream doesn't cause hormone-related side effects in the body.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

The study found a specific pattern of uneven melanin distribution on balding scalps that could help understand skin diseases caused by light exposure.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Untreated congenital adrenal hyperplasia can lead to complications like stroke and needs glucocorticoid treatment.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Finasteride doesn't affect ovulation in normal women.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.